宫内皮质瘤1级和进展的长期风险和治疗
Ingrid Baasland1,2, Tone Bjørge1,3, Birgit Engesæter1
1Section for Cervical Cancer Screening, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
PloS one
|April 23, 2025
概括
对1级子宫内皮质瘤 (CIN1) 的积极监测可能需要调整后续检查. 长期数据显示,CIN2+和CIN3+的进展风险显著,特别是高风险HPV类型,为管理策略提供了信息.
科学领域:
- 妇科 妇科医生 妇科
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 宫内皮质瘤1级 (CIN1) 由于感知进展风险较低,通常通过积极监测进行管理.
- 然而,关于CIN1进展和治疗发生的长期数据有限.
- 本研究旨在通过评估长期结果,提供对CIN1管理的见解.
研究的目的:
- 估计患有高度子宫病变 (CIN2+) 的进展风险和在被诊断为CIN1.1的妇女中治疗的发生率.
- 为制定基于证据的CIN1.1管理和后续指导方针提供信息.
- 分析基于初始细胞学和HPV状态的进展风险.
主要方法:
- 利用来自挪威宫癌查计划 (2002-2019) 的全国性注册表数据.
- 包括26,130名第一次经过组织学确认的CIN1诊断的妇女.
- 随着时间的推移,对参与者进行了CIN2+ (CIN2,CIN3,AIS或宫癌) 的检测和治疗.
主要成果:
- 在五年内,CIN2+的累积发病率达到19.0%.
- 具有高度细胞学或HPV16/18阳性状态的女性显示了更高的5年累积发病率 (分别为26.0%和25.0%).
- 5年后,CIN3+的累积发病率为12.7%,治疗5年的发病率为15.2%.
结论:
- 对CIN1的进展和治疗风险很大,特别是在具有特定细胞学和HPV配置文件的女性中.
- 目前的积极监控策略可能需要改进.
- 建议对CIN1管理进行差异化的后续指南,考虑索引细胞学和HPV16/18状态.
更多相关视频
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
9.6K
06:57Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
10.3K
相关概念视频
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Barrett Esophagus-I: Introduction
41
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
41
